November 18, 2013 at 16:51 PM EST
BRIEF-Pfizer gets FDA Approval for additional use of Xeljanz in Rheumatoid Arthritis
Nov 18 (Reuters) - Pfizer : * Announces FDA approval of supplemental application to expand xeljanz
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here